News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
|
Followers
|
4
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3
|
|
Created
|
10/26/08
|
Type
|
Free
|
| Moderators | |||
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases.
Contact Information Business Description Kyto Biopharma, Inc.
B1-114 Belmont Avenue
Toronto, ONT M5R 1P8
Canada
OTC Market Tier
Pink Quote/OTCBBBusiness Stage
Shell Company
State Of Incorporation
FLJurisdiction Of Incorporation
United States
Company Officers
Jean-Luc Berger, President, CEO, CFO
CIK
0001164888Fiscal Year End
12/31
Estimated Market Cap
$38,230,830 as of Oct 24, 2008Outstanding Shares
12,743,610 as of Aug 8, 2008Number of Share Holders of Record
16 as of Jul 1, 2008
Company Notes
Transfer Agent
OTC Stock Transfer, Inc.
231 E. 2100 South
Salt Lake City, UT 84165
Kyto Biopharma, Inc.
B1-114 Belmont Avenue
Toronto, ONT M5R 1P8
Canada
